Pharmacological activation of AMPK by AICAR or its inhibition by compound C [19] is therefore unlikely to significantly modify disease in mutant SOD1 mice or provide an effective therapeutic benefit in ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.